PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.74 -1.17 (-5.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Net Equity Issued and Repurchased (2021 - 2024)

PROCEPT BioRobotics (PRCT) posted quarterly Net Equity Issued and Repurchased of $164.5 million for Q4 2024, up 12863.62% quarter-over-quarter from -$1.3 million in Q3 2022.

PROCEPT BioRobotics (PRCT) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $164.5 million the latest figure, recorded in Q4 2024.

  • In Q4 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $164.5 million; the TTM figure through Dec 2024 stood at $163.2 million (up 12763.62% YoY), while the FY2024 annual figure was $164.5 million, up 1.74% from the prior year.
  • Net Equity Issued and Repurchased advanced to $164.5 million in Q4 2024 per PRCT's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $164.5 million in Q4 2024 and bottomed at -$1.3 million in Q3 2022.
  • Historically, Net Equity Issued and Repurchased has averaged $82.7 million across 3 years, with a median of $85.0 million in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 PROCEPT BioRobotics 1.19 Bn 911.91 Mn 62.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 164.52 Mn
Dec 31, 2024 164.52 Mn
Sep 30, 2022 -1.29 Mn
Sep 30, 2022 -1.29 Mn
Jun 30, 2021 85.00 Mn
Jun 30, 2021 85.00 Mn